Literature DB >> 8820179

Apolipoprotein E in the brain and its role in Alzheimer's disease.

J Poirier1.   

Abstract

Recent evidence indicates that apolipoprotein E (apoE) plays a central role in the brain response to injury. The coordinated expression of apoE and its main receptor, the apoE/apoB (LDL) receptor, appears to regulate the transport of cholesterol and phospholipids during the different phases of the reinnervation process. The recent discovery that a peculiar form of apoE, the apoE4, is strongly linked to both sporadic and familial late onset Alzheimer's disease (AD) raises the possibility that a dysfunction of the lipid transport system associated with compensatory sprouting and synaptic remodelling could be central to the AD process. The role of apoE in the central nervous system (CNS) is particularly important in relation to the function of the cholinergic system which relies to a certain extent on the integrity of phospholipid homeostasis in neurons. Recent evidence suggests that apoE4 allele has a direct impact on cholinergic function in AD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8820179      PMCID: PMC1188752     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  44 in total

1.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

2.  Human apolipoprotein E. The complete amino acid sequence.

Authors:  S C Rall; K H Weisgraber; R W Mahley
Journal:  J Biol Chem       Date:  1982-04-25       Impact factor: 5.157

3.  Nucleotide sequence and structure of the human apolipoprotein E gene.

Authors:  Y K Paik; D J Chang; C A Reardon; G E Davies; R W Mahley; J M Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

4.  The LDL receptor gene: a mosaic of exons shared with different proteins.

Authors:  T C Südhof; J L Goldstein; M S Brown; D W Russell
Journal:  Science       Date:  1985-05-17       Impact factor: 47.728

5.  Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.

Authors:  K Blennow; C Hesse; P Fredman
Journal:  Neuroreport       Date:  1994-12-20       Impact factor: 1.837

6.  The locus for apolipoprotein E (apoE) is linked to the complement component C3 (C3) locus on chromosome 19 in man.

Authors:  B Olaisen; P Teisberg; T Gedde-Dahl
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

7.  Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by lipoproteins.

Authors:  M S Brown; S E Dana; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

8.  Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue.

Authors:  E K Perry; P H Gibson; G Blessed; R H Perry; B E Tomlinson
Journal:  J Neurol Sci       Date:  1977-11       Impact factor: 3.181

9.  Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

Authors:  B T Hyman; G W Van Hoesen; A R Damasio; C L Barnes
Journal:  Science       Date:  1984-09-14       Impact factor: 47.728

10.  Plasticity of hippocampal circuitry in Alzheimer's disease.

Authors:  J W Geddes; D T Monaghan; C W Cotman; I T Lott; R C Kim; H C Chui
Journal:  Science       Date:  1985-12-06       Impact factor: 47.728

View more
  14 in total

Review 1.  Traumatic brain injury as a risk factor for Alzheimer's disease: a review.

Authors:  T C Lye; E A Shores
Journal:  Neuropsychol Rev       Date:  2000-06       Impact factor: 7.444

Review 2.  Genetic influences on outcome following traumatic brain injury.

Authors:  Barry D Jordan
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

Review 3.  Revisiting APP secretases: an overview on the holistic effects of retinoic acid receptor stimulation in APP processing.

Authors:  José J M Vitória; Diogo Trigo; Odete A B da Cruz E Silva
Journal:  Cell Mol Life Sci       Date:  2022-01-28       Impact factor: 9.261

4.  BACE1 levels by APOE genotype in non-demented and Alzheimer's post-mortem brains.

Authors:  Boris Decourt; Amanda Gonzales; Thomas G Beach; Michael Malek-Ahmadi; Aaron Walker; Lucia Sue; Douglas G Walker; Marwan N Sabbagh
Journal:  Curr Alzheimer Res       Date:  2013-03       Impact factor: 3.498

5.  The human secretome atlas initiative: implications in health and disease conditions.

Authors:  Kristy J Brown; Haeri Seol; Dinesh K Pillai; Binu-John Sankoorikal; Catherine A Formolo; Jenny Mac; Nathan J Edwards; Mary C Rose; Yetrib Hathout
Journal:  Biochim Biophys Acta       Date:  2013-04-19

6.  APOE polymorphisms and cognitive functions in patients with brain tumors.

Authors:  Denise D Correa; Jaya Satagopan; Raymond E Baser; Kenneth Cheung; Elizabeth Richards; Michael Lin; Sasan Karimi; John Lyo; Lisa M DeAngelis; Irene Orlow
Journal:  Neurology       Date:  2014-06-18       Impact factor: 9.910

7.  Metabolic response to a ketogenic breakfast in the healthy elderly.

Authors:  E Freemantle; M Vandal; J Tremblay Mercier; M Plourde; J Poirier; S C Cunnane
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

8.  Exogenous visual orienting is associated with specific neurotransmitter genetic markers: a population-based genetic association study.

Authors:  Rebecca A Lundwall; Dong-Chuan Guo; James L Dannemiller
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

9.  Tissue-Specific Effects of Loss of Estrogen during Menopause and Aging.

Authors:  Korinna Wend; Peter Wend; Susan A Krum
Journal:  Front Endocrinol (Lausanne)       Date:  2012-02-08       Impact factor: 5.555

10.  Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats.

Authors:  Rajeshkumar U Koladiya; Amteshwar S Jaggi; Nirmal Singh; Bhupesh K Sharma
Journal:  BMC Pharmacol       Date:  2008-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.